Inflammatory Bowel Disease Clinical Trials in Toronto, Ontario
5 recruitingToronto, Ontario, Canada
Showing 1–5 of 5 trials
Recruiting
Phase 1
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmRheumatoid Arthritis+11 more
National Cancer Institute (NCI)300 enrolled52 locationsNCT03816345
Recruiting
Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)
Ulcerative Colitis (UC)Crohn Disease (CD)Inflammatory Bowel Disease (IBD)+1 more
TIDHI Innovation Inc.200 enrolled9 locationsNCT07245394
Recruiting
Genome Analysis Across Populations in Inflammatory Bowel Disease
HealthyInflammatory Bowel DiseasesCrohn Disease+1 more
Mount Sinai Hospital, Canada150 enrolled1 locationNCT06042387
Recruiting
Not Applicable
IBD Neoplasia Surveillance RCT
Inflammatory Bowel DiseasesColonic NeoplasmsDysplasia
Ottawa Hospital Research Institute1,952 enrolled11 locationsNCT05809999
Recruiting
The Canadian Children Inflammatory Bowel Disease Network (CIDsCaNN)
Inflammatory Bowel DiseasesUlcerative ColitisCrohn's
The Hospital for Sick Children2,400 enrolled12 locationsNCT02308917